Literature DB >> 21142489

Comparison of second-generation stents for application in the superficial femoral artery: an in vitro evaluation focusing on stent design.

Stefan Müller-Hülsbeck1, Philipp J Schäfer, Nikolas Charalambous, Hiroshi Yagi, Martin Heller, Thomas Jahnke.   

Abstract

PURPOSE: To examine and compare in an ex vivo study different nitinol stent designs intended for the superficial femoral artery (SFA) with regard to the appearance of fracture.
METHODS: Seven different 8-×40-mm nitinol stents were evaluated (Misago, Absolute, Smart, Luminexx, Sentinol, Lifestent NT, and Sinus-Superflex). Finite element analysis (FEA) was used for digitalized stent design comparison; the strain during stent movement was calculated for bending, compression, and torsion. Additional mechanical fatigue tests for bending (70°), compression (40%), and torsion (twisted counterclockwise by 180°) were performed up to 650,000 cycles or until a fracture was observed.
RESULTS: The FEA bending test showed that only the Misago, LifeStent, and Absolute stents presented no zones of high strain; in the torsion test, the Smart stent also had no zones of high strain. Macroscopic evaluation after mechanical bending indicated that the LifeStent performed the best (no stent fracture after 650,000 cycles). Misago and Absolute stents showed fractures at 536,000 cycles and 456,667 cycles, respectively (range 320,000-650,000 cycles). After compression and torsion testing, Misago showed no stent fracture after 650,000 cycles. The worst performing stent was Luminexx during all test cycles.
CONCLUSION: The 7 SFA stents showed differences in the incidence of high strain zones, which indicates a potential for stent fracture, as demonstrated by the mechanical fatigue tests. Differences in stent design might play a major role in the appearance of stent strut fracture related to restenosis and reocclusion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21142489     DOI: 10.1583/10-3069.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  6 in total

1.  Evolution of patency rates of self-expandable bare metal stents for endovascular treatment of femoro-popliteal arterial occlusive disease: Does stent design matter?

Authors:  Karla Maria Treitl; Benedikt Woerner; Regina Schinner; Michael Czihal; Susan Notohamiprodjo; Ulrich Hoffmann; Marcus Treitl
Journal:  Eur Radiol       Date:  2017-02-06       Impact factor: 5.315

2.  Fatigue and in vivo validation of a peritoneum-lined self-expanding nitinol stent-graft.

Authors:  Jennifer M Bastijanic; Jordan Etscheidt; Mallika Sattiraju; Craig Bonsignore; George Kopchok; Rodney White; Timur P Sarac
Journal:  J Endovasc Ther       Date:  2014-10       Impact factor: 3.487

Review 3.  Nitinol Stents in the Femoropopliteal Artery: A Mechanical Perspective on Material, Design, and Performance.

Authors:  Kaspars Maleckis; Eric Anttila; Paul Aylward; William Poulson; Anastasia Desyatova; Jason MacTaggart; Alexey Kamenskiy
Journal:  Ann Biomed Eng       Date:  2018-02-22       Impact factor: 3.934

4.  Nitinol Self-Expanding Stents for the Treatment of Obstructive Superficial Femoral Artery Disease: Three-Year Results of the RELIABLE Japanese Multicenter Study.

Authors:  Masato Nakamura; Michael R Jaff; Richard A Settlage; Kimihiko Kichikawa
Journal:  Ann Vasc Dis       Date:  2018-09-25

5.  Mechanical and physio-biological properties of peptide-coated stent for re-endothelialization.

Authors:  In-Ho Bae; Myung Ho Jeong; Dae Sung Park; Kyung Seob Lim; Jae Won Shim; Mun Ki Kim; Jun-Kyu Park
Journal:  Biomater Res       Date:  2020-01-23

6.  Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.

Authors:  Sang Ho Park; Seung Woon Rha; Cheol Ung Choi; Eung Ju Kim; Dong Joo Oh; Yun Hyeong Cho; Woong Gil Choi; Seung Jin Lee; Yong Hoon Kim; Seung Hyuk Choi; Won Ho Kim; Ki Chang Kim; Jang Hyun Cho; Joo Han Kim; Sang Min Kim; Jang Ho Bae; Jung Min Bong; Won Yu Kang; Ju Yeol Baek; Jae Bin Seo; Woo Young Chung; Mahn Won Park; Sung Ho Her; Jon Suh; Min Woong Kim; Yeo Joo Kim; Hwan Jun Choi; Jae Wan Soh
Journal:  Trials       Date:  2014-09-10       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.